keyword
https://read.qxmd.com/read/37375736/innate-vascular-failure-by-application-of-neuroleptics-amphetamine-and-domperidone-rapidly-induced-severe-occlusion-occlusion-like-syndromes-in-rats-and-stable-gastric-pentadecapeptide-bpc-157-as-therapy
#21
JOURNAL ARTICLE
Sanja Strbe, Ivan Maria Smoday, Ivan Krezic, Luka Kalogjera, Vlasta Vukovic, Helena Zizek, Slaven Gojkovic, Hrvoje Vranes, Ivan Barisic, Suncana Sikiric, Marijan Tepes, Katarina Oroz, Filip Brkic, Martin Drinkovic, Lidija Beketic Oreskovic, Jelena Popic, Alenka Boban Blagaic, Anita Skrtic, Mario Staresinic, Sven Seiwerth, Predrag Sikiric
Even before behavioral disturbances, neuroleptics, amphetamine, and domperidone application rapidly emerged severe occlusion/occlusion-like syndrome, shared innate vascular and multiorgan failure in rats, comparable to occlusion/occlusion-like syndrome described with vessel(s) occlusion or similar noxious procedures application. As therapy, i.e., activation of the collateral pathways, "bypassing key" (activated azygos vein pathway, direct blood flow delivery), the stable gastric pentadecapeptide BPC 157 is a novel solution...
May 25, 2023: Pharmaceuticals
https://read.qxmd.com/read/37358825/social-psychopharmacology-novel-approaches-to-treat-deficits-in-social-motivation-in-schizophrenia
#22
JOURNAL ARTICLE
Anya K Bershad, Harriet de Wit
BACKGROUND AND HYPOTHESIS: Diminished social motivation is a negative symptom of schizophrenia and leads to severe functional consequences for many patients suffering from the illness. However, there are no effective medications available to treat this symptom. Despite the lack of approved treatments for patients, there is a growing body of literature on the effects of several classes of drugs on social motivation in healthy volunteers that may be relevant to patients. The aim of this review is to synthesize these results in an effort to identify novel directions for the development of medications to treat reduced social motivation in schizophrenia...
June 26, 2023: Schizophrenia Bulletin
https://read.qxmd.com/read/37269769/does-drug-use-affect-the-efficacy-of-amisulpride-aripiprazole-and-olanzapine-in-patients-with-schizophrenia-spectrum-disorders-results-from-a-pragmatic-randomised-study
#23
RANDOMIZED CONTROLLED TRIAL
Renata Alisauskiene, Erik Johnsen, Rolf Gjestad, Rune A Kroken, Eirik Kjelby, Igne Sinkeviciute, Farivar Fathian, Inge Joa, Solveig Klæbo Reitan, Maria Rettenbacher, Else-Marie Løberg
OBJECTIVES: Drug use is prevalent in patients with schizophrenia spectrum disorders (SSD) but there is limited knowledge about the influence of drug use on the effectiveness of antipsychotic medication. This secondary explorative study compared the effectiveness of three antipsychotics in patients with SSD, with and without drug use. METHODS: The BeSt InTro multi-centre, head to head, rater-blinded randomised study compared amisulpride, aripiprazole and olanzapine over a 1-year follow-up period...
2023: General Hospital Psychiatry
https://read.qxmd.com/read/37259325/novel-multimodal-salicylamide-derivative-with-antidepressant-like-anxiolytic-like-antipsychotic-like-and-anti-amnesic-activity-in-mice
#24
JOURNAL ARTICLE
Elżbieta Żmudzka, Klaudia Lustyk, Monika Głuch-Lutwin, Małgorzata Wolak, Jolanta Jaśkowska, Marcin Kołaczkowski, Jacek Sapa, Karolina Pytka
Depression, anxiety, and schizophrenia may coexist in psychiatric patients. Moreover, these disorders are very often associated with cognitive impairments. However, pharmacotherapy of these conditions remains challenging due to limited drug effectiveness or numerous side effects. Therefore, there is an urgent need to develop novel multimodal compounds that can be used to treat depression, anxiety, and schizophrenia, as well as memory deficits. Thus, this study aimed to evaluate the potential antidepressant-like, anxiolytic-like, antipsychotic-like effects, and anti-amnesic properties, of the novel arylpiperazine derivative of salicylamide, JJGW07, with an affinity towards serotonin 5-HT1A , 5-HT2A , and 5-HT7 and dopamine D2 receptors...
January 24, 2023: Pharmaceuticals
https://read.qxmd.com/read/37208550/maternal-immune-activation-induces-cortical-catecholaminergic-hypofunction-and-cognitive-impairments-in-offspring
#25
JOURNAL ARTICLE
Blanca Perez-Palomar, Amaia M Erdozain, Ines Erkizia-Santamaría, Jorge E Ortega, J Javier Meana
BACKGROUND: Impairment of specific cognitive domains in schizophrenia has been associated with prefrontal cortex (PFC) catecholaminergic deficits. Among other factors, prenatal exposure to infections represents an environmental risk factor for schizophrenia development in adulthood. However, it remains largely unknown whether the prenatal infection-induced changes in the brain may be associated with concrete switches in a particular neurochemical circuit, and therefore, if they could alter behavioral functions...
May 20, 2023: Journal of Neuroimmune Pharmacology: the Official Journal of the Society on NeuroImmune Pharmacology
https://read.qxmd.com/read/37205452/kappa-opioid-receptor-antagonism-rescues-genetic-perturbation-of-dopamine-homeostasis-molecular-physiological-and-behavioral-consequences
#26
Felix P Mayer, Adele Stewart, Durairaj Ragu Varman, Amy E Moritz, James D Foster, Anthony W Owens, Lorena B Areal, Raajaram Gowrishankar, Michelle Velez, Kyria Wickham, Hannah Phelps, Rania Katamish, Maximilian Rabil, Lankupalle D Jayanthi, Roxanne A Vaughan, Lynette C Daws, Randy D Blakely, Sammanda Ramamoorthy
Aberrant dopamine (DA) signaling is implicated in schizophrenia, bipolar disorder (BPD), autism spectrum disorder (ASD), substance use disorder, and attention-deficit/hyperactivity disorder (ADHD). Treatment of these disorders remains inadequate. We established that the human DA transporter (DAT) coding variant (DAT Val559), identified in individuals with ADHD, ASD, or BPD, exhibits anomalous DA efflux (ADE) that is blocked by therapeutic amphetamines and methylphenidate. As the latter agents have high abuse liability, we exploited DAT Val559 knock-in mice to identify non-addictive agents that can normalize DAT Val559 functional and behavioral effects ex viv o and in vivo ...
May 3, 2023: bioRxiv
https://read.qxmd.com/read/37085011/activating-the-dorsomedial-and-ventral-midbrain-projections-to-the-striatum-differentially-impairs-goal-directed-action-in-male-mice
#27
JOURNAL ARTICLE
Kyna-Anne Conn, Simin Zou, Joyosmita Das, Suzy Alexander, Thomas Hj Burne, James P Kesby
The cognitive symptoms of schizophrenia are wide ranging and include impaired goal-directed action. This could be driven by an increase in dopamine transmission in the dorsomedial striatum, a pathophysiological hallmark of schizophrenia. Although commonly associated with psychotic symptoms, dopamine signalling in this region also modulates associative learning that aids in the execution of actions. To gain a better understanding of the role of subcortical dopamine in learning and decision-making, we assessed goal-directed action in male mice using the cross-species outcome-specific devaluation task (ODT)...
April 19, 2023: Neuropharmacology
https://read.qxmd.com/read/36860219/psychosis-induced-by-methylphenidate-in-children-and-young-patients-with-attention-deficit-hyperactivity-disorder
#28
REVIEW
Khadija Pasha, Salomi Paul, Muhammad S Abbas, Sondos T Nassar, Tasniem Tasha, Anjali Desai, Anjana Bajgain, Asna Ali, Chandrani Dutta, Abeer O Elshaikh
Attention-deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders diagnosed in children of this era. ADHD in children and adults is challenging but highly manageable. Children with ADHD cannot focus, are hyperactive, and appear withdrawn. These symptoms make them endure difficulties in learning and create academic challenges. Methylphenidate (MPH) is one of the psychostimulants used as a first-line therapy for ADHD. In this literature review, we have gathered information that describes the evidence of psychotic symptoms in children and young patients with ADHD as a side effect of MPH...
January 2023: Curēus
https://read.qxmd.com/read/36854793/behavioural-effects-of-aph199-a-selective-dopamine-d4-receptor-agonist-in-animal-models
#29
JOURNAL ARTICLE
Daria Chestnykh, Fabian Graßl, Canice Pfeifer, Jonas Dülk, Chiara Ebner, Mona Walters, Stephan von Hörsten, Johannes Kornhuber, Liubov S Kalinichenko, Markus Heinrich, Christian P Müller
RATIONALE: The dopamine D4 receptors (DRD4) play a key role in numerous brain functions and are involved in the pathogenesis of various psychiatric disorders. DRD4 ligands have been shown to moderate anxiety, reward and depression-like behaviours, and cognitive impairments. Despite a series of promising but ambiguous findings, the therapeutic advantages of DRD4 stimulation remain elusive. OBJECTIVES: The investigation focused on the behavioural effects of the recently developed DRD4 agonist, APH199, to evaluate its impact on anxiety, anhedonia, behavioural despair, establishment and retrieval of alcohol reinforcement, and amphetamine (AMPH)-induced symptoms...
February 28, 2023: Psychopharmacology
https://read.qxmd.com/read/36813955/sleep-deprivation-induces-dopamine-system-maladaptation-and-escalated-corticotrophin-releasing-factor-signaling-in-adolescent-mice
#30
JOURNAL ARTICLE
Li-Heng Tuan, Jin-Wei Yeh, Lukas Jyuhn-Hsiarn Lee, Li-Jen Lee
Sleep disruption is highly associated with the pathogenesis and progression of a wild range of psychiatric disorders. Furthermore, appreciable evidence shows that experimental sleep deprivation (SD) on humans and rodents evokes anomalies in the dopaminergic (DA) signaling, which are also implicated in the development of psychiatric illnesses such as schizophrenia or substance abuse. Since adolescence is a vital period for the maturation of the DA system as well as the occurrence of mental disorders, the present studies aimed to investigate the impacts of SD on the DA system of adolescent mice...
June 2023: Molecular Neurobiology
https://read.qxmd.com/read/36799101/dexamphetamine-influences-funneling-illusion-based-on-psychometric-score
#31
JOURNAL ARTICLE
Faiz M Kassim, J H Mark Lim, Matthew A Albrecht, Mathew T Martin-Iverson
OBJECTIVES: Our team previously showed that like the experience of the rubber hand illusion (RHI) in people with schizophrenia and their offspring¸ dexamphetamine administration to healthy volunteers increases the stimulus binding windows (BWs) in RHI. It is not clear if similar expansions of BWs are present for unimodal illusions. Studies have also shown that subjective or objective effects of amphetamine would be linked to between-person variations in personality measures. Therefore, we aimed to examine the effect of dexamphetamine (DEX), a dopamine-releasing stimulant, on illusory perception using unimodal sensory stimuli (Tactile Funneling Illusion [TFI]) across both temporal and spatial variables...
February 17, 2023: Human Psychopharmacology
https://read.qxmd.com/read/36725976/life-time-use-of-illicit-substances-among-adolescents-and-young-people-hospitalized-in-psychiatric-hospital
#32
JOURNAL ARTICLE
Piotr Engelgardt, Maciej Krzyżanowski, Małgorzata Borkowska-Sztachańska, Agnieszka Wasilewska, Michał Ciucias
Adolescents are known to be particularly vulnerable, compared to children and adults, to initiation of substance use and progression to problematic use. This study aimed to examine the prevalence and type of illicit drug use in a population of adolescents and young adults who were hospitalized in a psychiatric hospital. The purpose of the study was also to find the link between age, sex, type of admission and particular mental disorders and using psychoactive substances at least once in a lifetime. A 12-month retrospective cross-sectional analysis of medical records compiled for adolescent and youth psychiatric patients who had been admitted to the Regional Psychiatric Hospital in Olsztyn, Poland, between October 1, 2018, and September 30, 2019, was conducted...
February 1, 2023: Scientific Reports
https://read.qxmd.com/read/36648708/ethyl-acetate-fraction-of-harpagophytum-procumbens-prevents-oxidative-stress-in-vitro-and-amphetamine-induced-alterations-in-mice-behavior
#33
JOURNAL ARTICLE
Valtieri Bortoluzzi Lima, Altevir Rossato Viana, Daniel Santos, Narieli Felipetto, Natália Fernandes Mezzomo, Adriana Maria Zago, Erico Marlon Moraes Flores, Alencar Kolinski Machado, Alexandre Krause, Luis Ricardo Peroza, Larissa Finger Schaffer, Luciana Maria Fontanari Krause
Microglial activation has been associated to the physiopathology of neurodegenerative diseases, such as schizophrenia, and can occur during inflammation and oxidative stress. Pharmacological treatment is associated with severe side effects, and studies for use of plant extracts may offer alternatives with lower toxicity. Harpagophytum procumbens (HP) is a plant known for its anti-inflammatory properties. In the present study, we characterized the ethyl acetate fraction of HP (EAF HP) by ESI-ToF-MS and investigated the effects EAF HP in a lipopolysaccharide (LPS) induced inflammation model on microglial cells (BV-2 lineage)...
January 17, 2023: Neurochemical Research
https://read.qxmd.com/read/36555774/reviewing-the-potential-therapeutic-approaches-targeting-the-modulation-of-gastrointestinal-microflora-in-schizophrenia
#34
REVIEW
Ilinca-Bianca Nita, Ovidiu-Dumitru Ilie, Alin Ciobica, Luminita-Diana Hritcu, Irina Dobrin, Bogdan Doroftei, Romeo Dobrin
Schizophrenia (SCZ) is a severe brain disorder characterized by an intriguing clinical panel that has begun to gain interest due to its particular phenotype. Having considered the role of gut microflora in psychiatry, the latest discoveries might offer further insight into the underlying mechanisms. Thus, we aimed to offer an updated overview of the therapeutic potential of microorganism-derived supplements alongside dedicated protocols that target the re-establishment of the host's eubiosis. Based on combinations of specific keywords, we performed searches in four databases (PubMed/Medline, ISI Web of Knowledge, Scopus, and ScienceDirect) for the established interval (2018-2022) and identified twenty two eligible cases, restricted only to human patients' experiences...
December 17, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/36555568/antipsychotic-and-anxiolytic-like-properties-of-a-multimodal-compound-jjgw08-in-rodents
#35
JOURNAL ARTICLE
Elżbieta Żmudzka, Klaudia Lustyk, Monika Głuch-Lutwin, Barbara Mordyl, Alicja Zakrzewska-Sito, Paweł Mierzejewski, Jolanta Jaśkowska, Marcin Kołaczkowski, Jacek Sapa, Karolina Pytka
Schizophrenia is a chronic mental illness, which remains difficult to treat. A high resistance to the available therapies, their insufficient efficacy, and numerous side effects are the reasons why there is an urgent need to develop new antipsychotics. This study aimed to assess the antipsychotic-like effects of JJGW08, a novel arylpiperazine alkyl derivative of salicylamide, in rodents. First, considering the JJGW08 receptor profile, we investigated the compound's intrinsic activity towards dopamine D2 and serotonin 5-HT1A , 5-HT2A , and 5-HT7 receptors using functional assays...
December 14, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/36421870/pharmacological-treatments-for-cocaine-craving-what-is-the-way-forward-a-systematic-review
#36
REVIEW
Dângela Layne Silva Lassi, André Malbergier, André Brooking Negrão, Lígia Florio, João P De Aquino, João Maurício Castaldelli-Maia
BACKGROUND: cocaine craving is a core feature of cocaine use disorder and remains a critical challenge for abstinence and relapse prevention. This review summarizes the anti-craving efficacy of pharmacotherapies tested for cocaine use disorder, in the context of randomized-controlled clinical trials. OBJECTIVES: we assessed the databases of the U.S. National Library of Medicine, Google Scholar, and PsycINFO, without date restrictions up to August 2022, to identify relevant studies...
November 14, 2022: Brain Sciences
https://read.qxmd.com/read/36402780/aras-recent-onset-acute-phase-psychosis-survey-a-prospective-observational-cohort-of-first-episode-psychosis-in-iran-the-cohort-profile
#37
JOURNAL ARTICLE
Sara Farhang, Maryam Shirzadi, Rosa Alikhani, Behrooz Z Alizadeh, Richard Bruggeman, Wim Veling
The Middle East is underrepresented in psychosis research. The ARAS recent onset acute phase psychosis survey (ARAS) is a longitudinal cohort across multiple centers in Iran, established to investigate characteristics, determinants and early course of psychosis in a non-Western, Middle East context. Here, baseline characteristics of the ARAS cohort are reported. The ARAS cohort enrolled patients with recent onset psychosis from September 2018 to September 2021 in East Azerbaijan, Kermanshah and Tehran, including Iranian patients from different sociocultural contexts...
November 19, 2022: Schizophrenia (Heidelb)
https://read.qxmd.com/read/36383348/association-of-pharmacological-treatments-and-hospitalization-and-death-in-individuals-with-amphetamine-use-disorders-in-a-swedish-nationwide-cohort-of-13%C3%A2-965-patients
#38
RANDOMIZED CONTROLLED TRIAL
Milja Heikkinen, Heidi Taipale, Antti Tanskanen, Ellenor Mittendorfer-Rutz, Markku Lähteenvuo, Jari Tiihonen
IMPORTANCE: There are no medications approved by authorities for the treatment of amphetamine or methamphetamine dependence, and studies investigating the effectiveness of pharmacological treatments in hard outcomes, such as hospitalization and death, are lacking. OBJECTIVE: To investigate the association between pharmacotherapies and hospitalization and mortality outcomes in persons with amphetamine or methamphetamine use disorder. DESIGN, SETTING, AND PARTICIPANTS: This nationwide register-based cohort study was conducted from July 2006 to December 2018 with a median (IQR) follow-up time of 3...
January 1, 2023: JAMA Psychiatry
https://read.qxmd.com/read/36380221/the-effect-of-selective-nigrostriatal-dopamine-excess-on-behaviors-linked-to-the-cognitive-and-negative-symptoms-of-schizophrenia
#39
JOURNAL ARTICLE
Nicolette A Moya, Seongsik Yun, Stefan W Fleps, Madison M Martin, Jacob A Nadel, Lisa R Beutler, Larry S Zweifel, Jones G Parker
Excess dopamine release in the dorsal striatum (DS) is linked to psychosis. Antipsychotics are thought to work by blocking striatal D2 dopamine receptors, but they lack efficacy for the negative and cognitive symptoms of schizophrenia. These observations and the fact that increasing brain-wide dopamine improves cognition have fueled the dogma that excess dopamine is not involved in negative and cognitive symptoms. However, this idea has never been explicitly tested with DS-pathway specificity. To determine if excess DS dopamine is involved in cognitive and negative symptoms, we selectively re-expressed excitatory TRPV1 receptors in DS-projecting dopamine neurons of Trpv1 knockout mice...
March 2023: Neuropsychopharmacology
https://read.qxmd.com/read/36048389/therapeutic-antischizophrenic-activity-of-prodigiosin-and-selenium-co-supplementation-against-amphetamine-hydrochloride-induced-behavioural-changes-and-oxidative-inflammatory-and-apoptotic-challenges-in-rats
#40
JOURNAL ARTICLE
Khalaf F Alsharif, Ashraf Albrakati, Naif E Al Omairi, Abdulraheem S Almalki, Walaa F Alsanie, Zakaria Y Abd Elmageed, Ola A Habotta, Maha S Lokman, Hussam A Althagafi, Abdullah A A Alghamdi, Ahmed E Abdel Moneim, Hussain Alyami, Saied K M Belal, Ghaliah Alnefaie, Abdulhakeem S Alamri, Nisreen Khalid Aref Albezrah, Rami B Kassab, Alaa Jameel A Albarakati, Khalid Ebraheem Hassan, Ahmad Agil
Schizophrenia (SCZ), a multifactorial neuropsychiatric disorder, is treated with inefficient antipsychotics and linked to poor treatment outcomes. This study, therefore, investigated the combined administration of prodigiosin (PDG) and selenium (Na2 SeO3 ) against SCZ induced by amphetamine (AMPH) in rats. Animals were allocated into four groups corresponding to their respective 7-day treatments: control, AMPH (2 mg/kg), PDG (300 mg/kg) + Na2 SeO3 (2 mg/kg), and AMPH + PDG + Na2 SeO3 . The model group exhibited biochemical, molecular, and histopathological changes similar to those of the SCZ group...
September 1, 2022: Environmental Science and Pollution Research International
keyword
keyword
77679
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.